FIELD: medicine, pharmacy. SUBSTANCE: invention proposes medicinal form of heparin for injection that contains 100-500 U/ml without toxic preserving agent and using in pediatry. Composition has,: heparin 0.075-0.56; sodium hydrogen phosphate 4.24-4.28; citric acid 0.24-0.26, and apyrogenic water - the rest, pH value of solution is 6.8-7.5. Sterility of solution is provided by sterilizing filtration in combination with the steam sterilization (at 110 C for 15 min). Preparation retains biological activity for 2 years. Preparation is used in pediatry as anticoagulating agent in ampoules (volume is 1 or 2 ml) containing 100 and 500 U/1 ml. EFFECT: enhanced effectiveness of preparation. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING OF INSULIN AQUEOUS SOLUTION | 1992 |
|
RU2020954C1 |
PREPARATION FOR TREATMENT OF BURN DISEASE OF EYE OF I-IV DEGREE | 1992 |
|
RU2073523C1 |
AGENT FOR ARTHROLOGICAL DISEASES TREATMENT | 1992 |
|
RU2021812C1 |
METHOD OF HEPARIN PREPARING | 1992 |
|
RU2042356C1 |
METHOD OF DEXTRAN CLINICAL FRACTIONS PURIFICATION | 1991 |
|
RU2021284C1 |
METHOD FOR OBTAINING CURATIVE PREPARATION FOR INJECTIONS | 2002 |
|
RU2209070C1 |
MEDICINAL PREPARATION FOR STOMACH DISEASE TREATMENT | 1993 |
|
RU2054947C1 |
METHOD OF PREPARING PHARMACEUTICAL COMPOSITION SUSPENSION BASED ON SUBSTANCE OF GENETIC ENGINEERING (RECOMBINANT) HUMAN INSULIN | 2001 |
|
RU2185152C1 |
METHOD OF PREPARING PREPARATION "PENSULIN CC" OF INSULIN SUSPENSION FOR CARTRIDGE | 1999 |
|
RU2157698C1 |
METHOD OF PREPARING PHARMACEUTICAL COMPOSITION SOLUTION BASED ON SUBSTANCE OF GENE ENGINEERING (RECOMBINANT) HUMAN INSULIN | 2001 |
|
RU2184533C1 |
Authors
Dates
1997-10-20—Published
1992-10-28—Filed